Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000041

CEO bought 275,000 shares at an average $0.02 ($4,437)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

23 lines
Date Transaction Shares Price Value Owned after D/I
2019-06-28 Purchase : show line 1 in the form +10,000 $0.02 $160 24,439,097 D
2019-06-28 Purchase : show line 2 in the form +6,012 $0.02 $95 24,445,109 D
2019-06-28 Purchase : show line 3 in the form +43,988 $0.02 $704 24,488,097 D
2019-06-28 Purchase : show line 4 in the form +5,000 $0.02 $78 24,493,097 D
2019-06-28 Purchase : show line 5 in the form +25,000 $0.02 $395 24,518,097 D
2019-06-28 Purchase : show line 6 in the form +5,000 $0.02 $78 24,523,097 D
2019-06-28 Purchase : show line 7 in the form +25,000 $0.02 $398 24,548,097 D
2019-07-01 Purchase : show line 8 in the form +5,000 $0.02 $78 24,553,097 D
Open-market purchases · 275,000 sh · avg $0.02 · $4,437
Loading xslF345X03/primary_doc.xml…